Phase-2 trial of indigenously developed Covaxin begins in Nagpur
Phase-2 trial of indigenously developed Covaxin begins in Nagpur
Nagpur based Gillurkar hospital has started the second round of trial of indigenously made Covaxin. 55 volunteers had undergone clinical trial in the first phase a few days ago.